Rekah Pharmaceutical Industry Ltd (REKA) — Financial Flexibility Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Financial Flexibility Index of 0.05x as of June 2026. Free cash flow of ILA14.31 Million (operating CF ILA13.82 Million minus capex ILA495.00K) represents 0% of total liabilities (ILA281.29 Million). Check REKA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Rekah Pharmaceutical Industry Ltd across 20 annual periods. For the full cash flow conversion analysis, see Rekah Pharmaceutical Industry Ltd (REKA) cash flow conversion.
Annual Financial Flexibility Index for Rekah Pharmaceutical Industry Ltd (2004–2025)
Year-by-year free cash flow to debt coverage for Rekah Pharmaceutical Industry Ltd. Explore REKA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | ILA19.98 Million | ILA12.95 Million | ILA279.47 Million | ▼ -42.1% |
| 2024 | 0.12x | ILA35.24 Million | ILA26.54 Million | ILA285.24 Million | ▲ +2.1% |
| 2023 | 0.12x | ILA39.84 Million | ILA28.35 Million | ILA329.14 Million | ▼ -25.4% |
| 2022 | 0.16x | ILA46.48 Million | ILA39.00 Million | ILA286.34 Million | ▲ +21.9% |
| 2021 | 0.13x | ILA35.16 Million | ILA21.17 Million | ILA264.02 Million | ▲ +12.4% |
| 2020 | 0.12x | ILA30.12 Million | ILA11.28 Million | ILA254.10 Million | ▼ -68.3% |
| 2019 | 0.37x | ILA79.31 Million | ILA33.91 Million | ILA211.89 Million | ▲ +72.5% |
| 2018 | 0.22x | ILA32.46 Million | ILA17.28 Million | ILA149.62 Million | ▼ -19.0% |
| 2017 | 0.27x | ILA40.27 Million | ILA23.80 Million | ILA150.33 Million | ▲ +60.2% |
| 2016 | 0.17x | ILA36.27 Million | ILA22.82 Million | ILA216.86 Million | ▲ +76.6% |
| 2015 | 0.09x | ILA18.95 Million | ILA5.81 Million | ILA200.17 Million | ▲ +7.1% |
| 2014 | 0.09x | ILA20.60 Million | ILA1.33 Million | ILA233.05 Million | ▲ +22.9% |
| 2013 | 0.07x | ILA16.09 Million | ILA11.71 Million | ILA223.65 Million | ▼ -32.0% |
| 2012 | 0.11x | ILA24.00 Million | ILA14.18 Million | ILA226.90 Million | ▲ +62.4% |
| 2010 | 0.07x | ILA14.61 Million | ILA6.73 Million | ILA224.18 Million | ▼ -60.5% |
| 2009 | 0.17x | ILA35.36 Million | ILA26.03 Million | ILA214.25 Million | ▲ +121.2% |
| 2008 | 0.07x | ILA17.30 Million | ILA6.57 Million | ILA231.87 Million | ▼ -1.6% |
| 2007 | 0.08x | ILA17.73 Million | ILA12.45 Million | ILA233.86 Million | ▲ +38.9% |
| 2005 | 0.05x | ILA11.36 Million | ILA4.27 Million | ILA208.15 Million | ▼ -63.0% |
| 2004 | 0.15x | ILA22.57 Million | ILA17.87 Million | ILA153.18 Million | — |